<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" bill-type="olc" dms-id="H28D677CA33174C9DABC21D816433E8D4" key="H" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 4841 RH: Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-01-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">IB</distribution-code>
		<calendar display="yes">Union Calendar No. 581</calendar>
		<congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session>
		<legis-num display="yes">H. R. 4841</legis-num>
		<associated-doc display="yes" role="report">[Report No. 115–747, Part I]</associated-doc>
		<current-chamber display="yes">IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action display="yes">
			<action-date date="20180118">January 18, 2018</action-date>
			<action-desc><sponsor name-id="S001183">Mr. Schweikert</sponsor> (for himself, <cosponsor name-id="L000570">Mr. Ben Ray Luján of New Mexico</cosponsor>, <cosponsor name-id="J000292">Mr. Johnson of Ohio</cosponsor>, and <cosponsor name-id="T000460">Mr. Thompson of California</cosponsor>) introduced the following bill; which was referred to the <committee-name added-display-style="italic" committee-id="HIF00" deleted-display-style="strikethrough">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc>
		</action>
		<action><action-date>June 12, 2018</action-date><action-desc>Additional sponsors: <cosponsor name-id="W000813">Mrs. Walorski</cosponsor>, <cosponsor name-id="M001198">Mr. Marshall</cosponsor>, <cosponsor name-id="R000592">Mr. Rokita</cosponsor>, <cosponsor name-id="Y000066">Mr. Young of Iowa</cosponsor>, <cosponsor name-id="B000574">Mr. Blumenauer</cosponsor>, <cosponsor name-id="N000188">Mr. Norcross</cosponsor>, <cosponsor name-id="D000628">Mr. Dunn</cosponsor>, <cosponsor name-id="S001187">Mr. Stivers</cosponsor>, <cosponsor name-id="K000376">Mr. Kelly of Pennsylvania</cosponsor>, <cosponsor name-id="R000586">Mr. Renacci</cosponsor>, <cosponsor name-id="B001293">Mr. Bishop of Michigan</cosponsor>, <cosponsor name-id="M001163">Ms. Matsui</cosponsor>, <cosponsor name-id="J000255">Mr. Jones</cosponsor>, <cosponsor name-id="S001191">Ms. Sinema</cosponsor>, <cosponsor name-id="S000250">Mr. Sessions</cosponsor>, <cosponsor name-id="R000606">Mr. Raskin</cosponsor>, <cosponsor name-id="B001243">Mrs. Blackburn</cosponsor>, <cosponsor name-id="W000791">Mr. Walden</cosponsor>, <cosponsor name-id="B001298">Mr. Bacon</cosponsor>, <cosponsor name-id="W000806">Mr. Webster of Florida</cosponsor>, <cosponsor name-id="C001096">Mr. Cramer</cosponsor>, <cosponsor name-id="S001150">Mr. Schiff</cosponsor>, and <cosponsor name-id="K000379">Mr. Kennedy</cosponsor></action-desc></action><action>
			<action-date>June 12, 2018</action-date>
			<action-desc>Reported from the Committee on <committee-name added-display-style="italic" committee-id="HIF00" deleted-display-style="strikethrough">Energy and Commerce</committee-name> with an amendment</action-desc>
			<action-instruction>Strike out all after the enacting clause and insert the part printed in italic</action-instruction>
		</action>
		<action><action-date>June 12, 2018</action-date><action-desc>The <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name> discharged; committed to the Committee of the Whole House on the State of the Union and ordered to
			 be printed</action-desc><action-instruction>For text of introduced bill, see copy of bill as introduced on January 18, 2018</action-instruction></action><action display="yes">
			<action-desc display="yes"><pagebreak></pagebreak></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title display="yes">To amend title XVIII of the Social Security Act to provide for electronic prior authorization under
			 Medicare part D for covered part D drugs, and for other purposes.<pagebreak></pagebreak></official-title>
	</form>
	<legis-body changed="added" committee-id="HIF00" display-enacting-clause="yes-display-enacting-clause" id="HD1517B4D257B4222B16BF60DDC372FDD" reported-display-style="italic" style="OLC">
 <section id="HD0043674BD8E4E8CA45FAAE8D40181EB" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018</short-title></quote>.</text> </section><section id="H82D9E35821414BC3A32EDC9183DFA1F6"><enum>2.</enum><header>Electronic prior authorization for covered part D drugs</header> <subsection id="H7635A02EB7A74CD2BD8D7F504B219896"><enum>(a)</enum><header>Inclusion in electronic prescription program</header><text display-inline="yes-display-inline">Section 1860D–4(e)(2) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-104">42 U.S.C. 1395w–104(e)(2)</external-xref>) is amended by adding at the end the following new subparagraph:</text>
				<quoted-block changed="added" committee-id="HIF00" display-inline="no-display-inline" id="HB45002B71A71443FAE5CE670C92A6F02" reported-display-style="italic" style="OLC">
					<subparagraph id="HF6B69B85B31143C9A9E83322C0FA3C70"><enum>(E)</enum><header>Electronic prior authorization</header>
 <clause id="H710728383B914E5F9C3014B182FE57FC"><enum>(i)</enum><header>In general</header><text display-inline="yes-display-inline">Not later than January 1, 2021, the program shall provide for the secure electronic transmittal of—</text> <subclause id="HA87F8585525440E494AB8D9703933DFD"><enum>(I)</enum><text>a prior authorization request from the prescribing health care professional for coverage of a covered part D drug for a part D eligible individual enrolled in a part D plan (as defined in section 1860D–23(a)(5)) to the PDP sponsor or Medicare Advantage organization offering such plan; and</text>
 </subclause><subclause id="HFFB6990C10DE46488396B5D287C07DD1"><enum>(II)</enum><text>a response, in accordance with this subparagraph, from such PDP sponsor or Medicare Advantage organization, respectively, to such professional.</text>
							</subclause></clause><clause id="HC0A3CA4726F84B798B942E1E6194FD98"><enum>(ii)</enum><header>Electronic transmission</header>
 <subclause id="H79D25DFB4FD249F5B22621B30C2A8FCB"><enum>(I)</enum><header>Exclusions</header><text>For purposes of this subparagraph, a facsimile, proprietary payer portal that meets such standards as specified by the Secretary, or electronic form shall not be treated as an electronic transmission described in clause (i).</text>
 </subclause><subclause id="H864D51E569E2404B8B39015056AF87EE"><enum>(II)</enum><header>Standards</header><text display-inline="yes-display-inline">In order to be treated, for purposes of this subparagraph, as an electronic transmission described in clause (i), such transmission shall comply with technical standards adopted by the Secretary in consultation with the National Council for Prescription Drug Programs, other standard setting organizations determined appropriate by the Secretary, and stakeholders including PDP sponsors, Medicare Advantage organizations, health care professionals, and health information technology software vendors.</text></subclause></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
 </subsection><subsection id="H22190B30B14D496395E2B128A7C975F3"><enum>(b)</enum><header>Sense of Congress regarding electronic prior authorization</header><text>It is the sense of the Congress that—</text> <paragraph id="H1C00B3D1BE584F83AFEAFE5137D5738E"><enum>(1)</enum><text display-inline="yes-display-inline">there should be increased use of electronic prior authorizations for coverage of covered part D drugs for part D eligible individuals enrolled in prescription drug plans under part D of title XVIII of the Social Security Act and MA–PD plans under part C of such title to reduce access delays by resolving coverage issues before prescriptions for such drugs are transmitted; and</text>
 </paragraph><paragraph id="H7024FA87B6C648F8A118DE4D9A6E4563"><enum>(2)</enum><text>greater priority should be placed on increasing the adoption of use of such electronic prior authorizations among prescribers of such drugs, pharmacies, PDP sponsors, and Medicare Advantage organizations.</text>
				</paragraph></subsection></section></legis-body>
	<endorsement display="yes">
		<action-date>June 12, 2018</action-date>
		<action-desc>Reported from the <committee-name added-display-style="italic" committee-id="HIF00" deleted-display-style="strikethrough">Committee on Energy and Commerce</committee-name> with an amendment</action-desc><action-date>June 12, 2018</action-date><action-desc>The <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name> discharged; committed to the Committee of the Whole House on the State of the Union and ordered to
			 be printed</action-desc></endorsement>
</bill>


